Organic Letters
Letter
Scheme 3. Proposed Mechanism
that are anti-diastereoselective to be converted into syn-
diastereoisomers. The methodology described provides a direct
method for the stereoselective synthesis of β-aminonitriles,
which will widen their use as chiral building blocks in target
synthesis.
(9) For example: Yadav, J. S.; Reddy, B. V. S.; Parimala, G.; Reddy, P.
V. Synthesis 2002, 2383 and references cited therein.
(
10) Anderson, J. C.; Blake, A. J.; Mills, M.; Ratcliffe, P. D. Org. Lett.
008, 10, 4141.
11) For example, see: Chhiba, V.; Bode, M. L.; Mathiba, K.; Kwezi,
W.; Brady, D. J. Mol. Catal. B: Enzym. 2012, 76, 68.
12) For a review of catalytic cyanoalkylation, see: Lop
C. Angew. Chem., Int. Ed. 2015, 54, 13170.
2
(
(
́
ez, R.; Palomo,
ASSOCIATED CONTENT
Supporting Information
■
*
S
(13) (a) Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456. (b) Richard, J.
P.; Williams, G.; Gao, J. J. Am. Chem. Soc. 1999, 121, 715.
(
14) Mecozzi, T.; Petrini, M.; Profeta, R. J. Org. Chem. 2001, 66,
264.
15) Viteva, L.; Gospodova, T.; Stefanovsky, Y.; Simova, S.
Tetrahedron 2005, 61, 5855.
16) (a) D’Sa, B. A.; Kisanga, P.; Verkade, J. G. J. Org. Chem. 1998,
3, 3961. (b) Kisanga, P.; McLeod, D.; D’Sa, B.; Verkade, J. G. J. Org.
Chem. 1999, 64, 3090.
17) (a) Poisson, T.; Gembus, V.; Oudeyer, S.; Marsais, F.; Levacher,
8
(
Experimental procedures, characterization data and
NMR spectra for all compounds; representation of X-
ray structure for syn-3 (PDF)
(
6
Crystallographic data for syn-3 (CIF)
(
V. J. Org. Chem. 2009, 74, 3516. (b) Hyodo, K.; Kondo, M.;
Funahashi, Y.; Nakamura, S. Chem. - Eur. J. 2013, 19, 4128.
AUTHOR INFORMATION
■
*
*
(
18) (a) Aydin, J.; Conrad, C. S.; Szabo,
́
K. J. Org. Lett. 2008, 10,
5
175. (b) Hyodo, K.; Nakamura, S.; Tsuji, K.; Ogawa, T.; Funahashi,
ORCID
Y.; Shibata, N. Adv. Synth. Catal. 2011, 353, 3385. (c) Zhao, J.; Liu, X.;
Luo, W.; Xie, M.; Lin, L.; Feng, X. Angew. Chem., Int. Ed. 2013, 52,
3473.
(19) Tian, M.; Yan, M.; Baran, P. S. J. Am. Chem. Soc. 2016, 138,
1
4234.
Present Addresses
(20) Robak, M. T.; Herbage, M. A.; Ellman, J. A. Chem. Rev. 2010,
†(
110, 3600.
21) The terms anti and syn are defined in this paper according to
I.B.C., S.C.) GlaxoSmithKline, Medicines Research Centre,
(
Stevenage SG1 2NY, UK.
‡
that proposed by Masamune. Masamune, S.; Ali, S. A.; Snitman, D. L.;
Garvey, D. S. Angew. Chem., Int. Ed. Engl. 1980, 19, 557.
(G.J.T.) National Crystallography Service, School of Chem-
istry, University of Southampton, Southampton SO17 1BJ, UK.
(22) (a) Anderson, J. C.; Blake, A. J.; Koovits, P. J.; Stepney, G. J. J.
Notes
Org. Chem. 2012, 77, 4711. (b) Anderson, J. C.; Horsfall, L. R.;
Kalogirou, A. S.; Mills, M. R.; Stepney, G. R.; Tizzard, G. J. J. Org.
Chem. 2012, 77, 6186. (c) Anderson, J. C.; Noble, A.; Tocher, D. A. J.
Org. Chem. 2012, 77, 6703. (d) Anderson, J. C.; Koovits, P. J. Chem.
Sci. 2013, 4, 2897. (e) Anderson, J. C.; Kalogirou, A. S.; Porter, M. J.;
Tizzard, G. J. Beilstein J. Org. Chem. 2013, 9, 1737. (f) Anderson, J. C.;
Kalogirou, A. S.; Tizzard, G. J. Tetrahedron 2014, 70, 9337.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work was supported by UCL the EPSRC and GSK (EP/
F068344/2).
■
(g) Anderson, J. C.; Campbell, I. B.; Campos, S.; Shannon, J.;
Tocher, D. A. Org. Biomol. Chem. 2015, 13, 170. (h) Anderson, J. C.;
Barham, J. P.; Rundell, C. D. Org. Lett. 2015, 17, 4090. (i) Anderson, J.
C.; Rundell, C. D. Synlett 2016, 27, 41. (j) Anderson, J. C.; Campbell,
I. B.; Campos, S.; Reid, I. H.; Rundell, C. D.; Shannon, J.; Tizzard, G.
J. Org. Biomol. Chem. 2016, 14, 8270.
REFERENCES
■
(
1) (a) Chemistry of the Cyano Group; Rappoport, Z., Patai, S., Eds.;
Wiley: London, 1970. (b) Fatiadi, A. J. In The Chemistry of Triple
Bonded Functional Groups, Part 2; Rappoport, Z., Patai, S., Eds.; Wiley:
London, 1983; Supplement C, pp 1057−1303.
(23) Unambiguous assignment of relative stereochemistry was
(
2) Fleming, F. F.; Yao, L.; Ravikumar, P. C.; Funk, L.; Shook, B. C. J.
Med. Chem. 2010, 53, 7902.
3) (a) Arseniyadis, S.; Kyler, K. S.; Watt, D. S. Org. React. 1984, 31,
. (b) Fleming, F. F. Nat. Prod. Rep. 1999, 16, 597.
4) Naruse, N.; Yamamoto, S.; Yamamoto, H.; Kondo, S.; Masuyoshi,
S.; Numata, K.-I.; Fukagawa, Y.; Oki, T. J. Antibiot. 1993, 46, 685.
5) Zeches, M.; Ravao, T.; Richard, B.; Massiot, G.; Le Men-Olivier,
L.; Verpoorte, R. J. Nat. Prod. 1987, 50, 714.
6) Mesa, R. A.; Yasothan, U.; Kirkpatrick, P. Nat. Rev. Drug Discovery
012, 11, 103.
7) For a recent review, see: Ji, X.; Huang, H. Org. Biomol. Chem.
016, 14, 10557.
8) For example: Saikia, M.; Deka, D. C.; Karmakar, S. Curr.
Microwave Chem. 2016, 3, 47 and references cited therein.
achieved through single-crystal X-ray crystallography of the prevailing
syn-diastereoisomer (syn-3) from a reaction using LHMDS. See the SI
and CCDC 1531946.
(
1
(
(24) Possible quenching of LHMDS by adventitious water over time
during use could increase the concentration of HMDS.
(
(
2
(
2
(
D
Org. Lett. XXXX, XXX, XXX−XXX